These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 20967505)

  • 1. Overdose prevention and naloxone prescription for opioid users in San Francisco.
    Enteen L; Bauer J; McLean R; Wheeler E; Huriaux E; Kral AH; Bamberger JD
    J Urban Health; 2010 Dec; 87(6):931-41. PubMed ID: 20967505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.
    Seal KH; Downing M; Kral AH; Singleton-Banks S; Hammond JP; Lorvick J; Ciccarone D; Edlin BR
    J Urban Health; 2003 Jun; 80(2):291-301. PubMed ID: 12791805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief overdose education is sufficient for naloxone distribution to opioid users.
    Behar E; Santos GM; Wheeler E; Rowe C; Coffin PO
    Drug Alcohol Depend; 2015 Mar; 148():209-12. PubMed ID: 25595053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario.
    Leece PN; Hopkins S; Marshall C; Orkin A; Gassanov MA; Shahin RM
    Can J Public Health; 2013 Apr; 104(3):e200-4. PubMed ID: 23823882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.
    Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
    J Urban Health; 2016 Feb; 93(1):117-30. PubMed ID: 26800987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overdose Education and Naloxone Distribution in the San Francisco County Jail.
    Wenger LD; Showalter D; Lambdin B; Leiva D; Wheeler E; Davidson PJ; Coffin PO; Binswanger IA; Kral AH
    J Correct Health Care; 2019 Oct; 25(4):394-404. PubMed ID: 31672075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-Based Response to Fentanyl Overdose Outbreak, San Francisco, 2015.
    Rowe C; Wheeler E; Stephen Jones T; Yeh C; Coffin PO
    J Urban Health; 2019 Feb; 96(1):6-11. PubMed ID: 29725887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing opiate overdose deaths: examining objections to take-home naloxone.
    Bazazi AR; Zaller ND; Fu JJ; Rich JD
    J Health Care Poor Underserved; 2010 Nov; 21(4):1108-13. PubMed ID: 21099064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Innovative Model for Naloxone Use Within an OTP Setting: A Prospective Cohort Study.
    Katzman JG; Takeda MY; Bhatt SR; Moya Balasch M; Greenberg N; Yonas H
    J Addict Med; 2018; 12(2):113-118. PubMed ID: 29227321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States.
    Green TC; Heimer R; Grau LE
    Addiction; 2008 Jun; 103(6):979-89. PubMed ID: 18422830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision.
    Barry T; Klimas J; Tobin H; Egan M; Bury G
    Br J Gen Pract; 2017 Apr; 67(657):e267-e273. PubMed ID: 28246098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.
    Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
    Addiction; 2015 Aug; 110(8):1301-10. PubMed ID: 25917125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
    McDonald R; Campbell ND; Strang J
    Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
    Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
    Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a naloxone distribution and administration program in New York City.
    Piper TM; Stancliff S; Rudenstine S; Sherman S; Nandi V; Clear A; Galea S
    Subst Use Misuse; 2008; 43(7):858-70. PubMed ID: 18570021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks and overdose responses: Participant characteristics from the first seven years of a national take-home naloxone program.
    Ericson ØB; Eide D; Lobmaier P; Clausen T
    Drug Alcohol Depend; 2022 Nov; 240():109645. PubMed ID: 36191532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for a multi-site study of the effects of overdose prevention education with naloxone distribution program in Skåne County, Sweden.
    Troberg K; Isendahl P; Blomé MA; Dahlman D; Håkansson A
    BMC Psychiatry; 2020 Feb; 20(1):49. PubMed ID: 32028921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
    Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
    Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
    Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.